| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chairman &CEO | Director
2 companies
Bentsur Ron is a Chairman &CEO at Nuvectis Pharma, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 17 buys and 4 sells.
Estimated insider holdings value: $44.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 18, 2022 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 2,010 | $19.48 | $39,155.30 | - | -51.4% | -10.7% | |
| May 16, 2022 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 1,700 | $18.82 | $31,990.00 | - | -51.1% | -11.1% | |
| May 12, 2022 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 12,245 | $16.99 | $208,046.70 | +0.1% | -53.2% | -10.5% | |
| Mar 28, 2022 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 4,000 | $7.05 | $28,200.00 | +0.1% | +76.4% | +75.2% | |
| Mar 17, 2022 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 7,000 | $7.63 | $53,410.00 | +0.2% | +33.2% | +56.6% | |
| Feb 14, 2022 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 8,000 | $5.88 | $47,040.00 | +0.3% | +251.2% | +97.8% | |
| Feb 10, 2022 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 8,500 | $6.34 | $53,890.00 | +0.3% | +157.6% | +133.3% | |
| Feb 7, 2022 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 232,500 | $4.96 | $1,153,145.00 | +2.1% | +89.4% | +37.0% | |
| Nov 24, 2021 | XAIR Beyond Air, Inc. | Director | Sell | 37,464 | $13.53 | $507,071.36 | -9.2% | -46.6% | -57.2% | |
| Feb 12, 2021 | XAIR Beyond Air, Inc. | - | Sale+OE | 24,919 | $6.36 | $158,364.84 | -6.4% | - | - |